| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |